METASTATIC NON SMALL CELL LUNG CANCER
Clinical trials for METASTATIC NON SMALL CELL LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NON SMALL CELL LUNG CANCER trials appear
Sign up with your email to follow new studies for METASTATIC NON SMALL CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cholesterol drug boost immunotherapy in lung cancer?
Disease control TerminatedThis study tested whether adding evolocumab (a cholesterol-lowering drug) to standard immunotherapy (nivolumab and ipilimumab) is safe and helps the immune system fight advanced non-small cell lung cancer. It included 19 people with newly diagnosed metastatic lung cancer who had …
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: PHASE2 • Sponsor: Eziafa Oduah, MD, PhD, MPH • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Pazopanib dose hunt in frail seniors halted early
Disease control TerminatedThis phase 1 study tested the cancer drug pazopanib in 18 frail elderly patients (aged 75+) with metastatic cancers like kidney, lung, or breast cancer. The goal was to find the highest safe dose by starting at 400 mg daily and increasing if tolerated. The study was terminated ea…
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Experimental combo for advanced lung cancer shows early promise but trial halted
Disease control TerminatedThis early-phase trial tested the combination of the immunotherapy drug pembrolizumab (Keytruda) with precise, high-dose radiation (SBRT) in patients with advanced non-small cell lung cancer that had progressed after chemotherapy. The study aimed to find the safest radiation dose…
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: Royal Marsden NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Experimental cell therapy for resistant lung cancer tested in tiny trial
Disease control TerminatedThis early-phase trial tested a new treatment called C-TIL051 for people with advanced non-small cell lung cancer that no longer responded to standard immunotherapy. The treatment involved taking immune cells from the patient's tumor, growing them in a lab, and infusing them back…
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: PHASE1 • Sponsor: AbelZeta Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can a smartphone app ease cancer treatment side effects?
Symptom relief TerminatedThis study tested whether a digital health app (Roche DPM Module) helps cancer patients manage symptoms and reduce healthcare visits while on systemic treatment. About 49 participants used the app alongside standard care. The trial was terminated early, so results are limited.
Matched conditions: METASTATIC NON SMALL CELL LUNG CANCER
Phase: PHASE2, PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC